Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Therapeutic switch from plasma to recombinant ADAMTS13 for patients with congenital TTP from Japanese real-world data

Kazuya Sakai, Atsushi Hamamura, Yoshiko Yoshimura, Miyuki Abe, Yoshiyuki Ogawa, Kazuki Tanaka, Norimichi Hattori, Tazuko Tokugawa, Rie Kanai, Fumiyoshi Ikejiri, Masahiro Takeyama, Teruhisa Taoka, Naoki Fujita, Minoru Kanaya, Katsuyoshi Koh, Hiroshi Shiragami, Hidekazu Azumi, Kenki Saito, Masanori Matsumoto

Blood blood.2024027516.

https://doi.org/10.1182/blood.2024027516

Published: 2025

Includes: Supplemental data

Journal Articles

Impact of Red Cell Distribution Width on Dysplasia and Clinical Outcome in 66 Patients with Myelodysplastic Syndrome without Increased Blasts

Yuta Baba, PhD MD, Bungo Saito, MD PhD, Shotaro Shimada, MD, Yohei Sasaki, MD, So Murai, MD, Maasa Abe, MD, Shun Fujiwara, MD, Nana Arai, MD, Yukiko Kawaguchi, MD, Nobuyuki Kabasawa, MD, Hiroyuki Tsukamoto, MD PhD, Yui Uto, MD PhD, Kouji Yanagisawa, MD, Norimichi Hattori, MD PhD, Hiroshi Harada, MD, Tsuyoshi Nakamaki, MD PhD

Blood (2018) 132 (Supplement 1): 5522.

https://doi.org/10.1182/blood-2018-99-113973

Published: 2018

Journal Articles

Increased C-Reactive Protein Level Is Associated with Poor Prognosis in Patients with Follicular Lymphoma Treated with Rituximab-Containing Regimens

Yukiko Kawaguchi, MD, Bungo Saito, MD PhD, Yohei Sasaki, MD, Shotaro Shimada, MD, Megumi Watanuki, MD, Maasa Abe, MD, So Murai, MD, Yuta Baba, MD, Shun Fujiwara, MD, Nana Arai, MD, Nobuyuki Kabasawa, MD, Hiroyuki Tsukamoto, MDPhD, Yui Uto, MD PhD, Kouji Yanagisawa, MD, Norimichi Hattori, MD PhD, Eisuke Shiozawa, MD PhD, Masafumi Takimoto, MD PhD, Tsuyoshi Nakamaki, MD PhD

Blood (2017) 130 (Supplement 1): 4067.

https://doi.org/10.1182/blood.V130.Suppl_1.4067.4067

Published: 2017

Journal Articles

Differential Expression of IL-17 Correlates with Clinical and Pathological Features of ITP

Naoko Okamoto, MD, Mayumi Homma, MD PhD, Yukiko Kawaguchi, MD, Nobuyuki Kabasawa, MD, Yui Uto, MD PhD, Shohei Yamamoto, MD PhD, Norimichi Hattori, MD PhD, Eisuke Shiozawa, MD PhD, Toshiko Yamochi, MD PhD, Keiichi Isoyama, MD PhD, Tsuyoshi Nakamaki, MD PhD, Masafumi Takimoto, MD PhD

Blood (2017) 130 (Supplement 1): 3644.

https://doi.org/10.1182/blood.V130.Suppl_1.3644.3644

Published: 2017

Journal Articles

High-Dose Ara-C, Carboplatin, Etoposide, and Steroids (ACES) Is Effective in Relapse and Refractory Non-Hodgkin Lymphoma

Nobuyuki Kabasawa, MD, Bungo Saito, MD PhD, Yohei Sasaki, MD, Shotaro Shimada, MD, Maasa Abe, MD, So Murai, MD, Yuta Baba, MD, Megumi Watanuki, MD, Yukiko Kawaguchi, MD, Nana Arai, MD, Shun Fujiwara, MD, Hiroyuki Tsukamoto, MDPhD, Yui Uto, MD PhD, Hirotsugu Ariizumi, MD, Kouji Yanagisawa, MD, Norimichi Hattori, MD PhD, Hiroshi Harada, MD, Tsuyoshi Nakamaki, MD PhD

Blood (2017) 130 (Supplement 1): 2850.

https://doi.org/10.1182/blood.V130.Suppl_1.2850.2850

Published: 2017

Journal Articles

Soluble Interleukin-2 Receptor and C-Reactive Protein Levels Are Associated with the Efficacy of Bendamustine As a Salvage Treatment for Indolent Lymphoma

Yukiko Kawaguchi, MD, Bungo Saito, MD, Maasa Abe, MD, Yuta Baba, MD, Sou Murai, MD, Megumi Watanuki, MD, Nana Arai, MD, Shun Fujiwara, MD, Nobuyuki Kabasawa, MD, Hiroyuki Tsukamoto, MD, Yui Uto, MD, Kouji Yanagisawa, MD, Norimichi Hattori, MD, Tsuyoshi Nakamaki, MD

Blood (2016) 128 (22): 1797.

https://doi.org/10.1182/blood.V128.22.1797.1797

Published: 2016

Journal Articles

Rituximab-Induced CD20-Mediated Signals and Suppression of PI3K-AKT Pathway Cooperates to Inhibit B-Cell Lymphoma Growth By Down-Regulation of Myc.

Tsuyoshi Nakamaki, MD, Yuta Baba, MD, Maasa Abe, MD, Sou Murai, MD, Megumi Watanuki, MD, Nobuyuki Kabasawa, MD, Kouji Yanagisawa, MD, Norimichi Hattori, MD, Yukiko Kawaguchi, MD, Nana Arai, MD, Shun Fujiwara, MD, Bungo Saito, MD

Blood (2016) 128 (22): 5312.

https://doi.org/10.1182/blood.V128.22.5312.5312

Published: 2016

Journal Articles

ASXL2 Is Recurrently Mutated in t(8;21) AML and Regulates Hematopoietic Development

Blood (2016) 128 (22): 1051.

https://doi.org/10.1182/blood.V128.22.1051.1051

Published: 2016

Journal Articles

Immunohistochemical Expression of CD123 Is Associated with an Inferior Clinical Outcome in Acute Myeloid Leukemia

Nana Arai, MD, Bungo Saito, MD, Maasa Abe, MD, Megumi Watanuki, MD, So Murai, MD, Yuta Baba, MD, Yukiko Kawaguchi, MD, Shun Fujiwara, MD, Hiroyuki Tsukamoto, MD, Yui Uto, MD, Nobuyuki Kabasawa, MD, Kouji Yanagisawa, MD, Norimichi Hattori, MD, Mayumi Homma, MD, Eisuke Shiozawa, MD, Toshiko Yamochi, MD, Masafumi Takimoto, MD, Hiroshi Harada, MD, Tsuyoshi Nakamaki, MD

Blood (2016) 128 (22): 2887.

https://doi.org/10.1182/blood.V128.22.2887.2887

Published: 2016

Journal Articles

Detection of Microbial Substitution in the Oral Cavity of Patients Undergoing Hematopoietic Stem Cell Transplantation with Vitek MS TM , a MALDI-TOF Mass Spectrometry System

Luna Osakabe, DDS, Bungo Saito, MD, Nana Arai, MD, Yukiko Kawaguchi, MD, Kouji Yanagisawa, MD, Norimichi Hattori, MD, Akemi Utsumi, DDS, Kunihiko Fukuchi, MD, Tsuyoshi Nakamaki, MD, Shouji Hironaka, DDS

Blood (2016) 128 (22): 5752.

https://doi.org/10.1182/blood.V128.22.5752.5752

Published: 2016

Journal Articles

Scoring System Using Age, C-Reactive Protein, Hemoglobin, and Albumin (ACHA) For Predicting Outcomes Of Diffuse Large B-Cell Lymphoma In The Rituximab-Era

Hirotsugu Ariizumi, MD, Bungo Saito, MD, Eisuke Shiozawa, MD, Yui Uto, MD, Norimichi Hattori, MD, Kouji Yanagisawa, MD, Hidetoshi Nakashima, MD, Hiroshi Harada, MD, Hiraku Mori, MD, Tsuyoshi Nakamaki, MD

Blood (2013) 122 (21): 4305.

https://doi.org/10.1182/blood.V122.21.4305.4305

Published: 2013

Journal Articles

Comprehensive Profiling of Somatic Mutations Which Define Primary Disease and Relapse in Various Acute Leukemia Subtypes

Blood (2012) 120 (21): 783.

https://doi.org/10.1182/blood.V120.21.783.783

Published: 2012

Journal Articles

Constitutive Cyclin A1 Expression Impairs Retinoic Acid-Induced Growth Arrest and Differentiation of Myeloid Leukemia Cells

Tsuyoshi Nakamaki, MD, Kunihiko Fukuchi, Takashi Maeda, Norimichi Hattori, Hirotsugu Ariizumi, Bungo Saito, MD, Takaji Yanagisawa, Isao Matsuda, Shigeru Tomoyasu

Blood (2010) 116 (21): 2894.

https://doi.org/10.1182/blood.V116.21.2894.2894

Published: 2010

Journal Articles

Constitutive Cyclin A1 Expression Induces Abrogation of Cell Cycle Check Points Associated with Ara-C Resistance in Myeloid Leukemia Cells.

Tsuyoshi Nakamaki, Kunihiko Fukuchi, Norimichi Hattori, Hidetoshi Nakashima, Takashi Maeda, Kouji Yanagisawa, Bungo Saito, Isao Matsuda, Shigeru Tomoyasu

Blood (2009) 114 (22): 4801.

https://doi.org/10.1182/blood.V114.22.4801.4801

Published: 2009

Journal Articles

Constitutive Cyclin A1 Expression Inhibits Cytosine Arabinoside-Induced Apoptosis in Myeloid Leukemia Cells.

Tsuyoshi Nakamaki, MD, Kunihiko Fukuchi, Hidetoshi Nakashima, Norimichi Hattori, Takashi Maeda, Hirotsugu Ariizumi, Daisuke Adachi, Bungo Saito, Takaji Yanagisawa, Isao Matsuda, Shigeru Tomoyasu

Blood (2008) 112 (11): 3370.

https://doi.org/10.1182/blood.V112.11.3370.3370

Published: 2008

Journal Articles

Characterization of Double BCR-ABL–positive Cell Lines Established from a Patient with Blasic Crisis of Chronic Myeloid Leukemia Who Showed Clinical Resistant to Imatinib

Tsuyoshi Nakamaki, Norimichi Hattori, Hidetoshi Nakashima, Takashi Maeda, Hirotsugu Ariizumi, Shigeru Tomoyasu

Blood (2008) 112 (11): 4244.

https://doi.org/10.1182/blood.V112.11.4244.4244

Published: 2008

Journal Articles

Treatment Effect of Rituximab Plus Chemotherapy Is Obtained by Improving Survival from Non-Germinal Center-Type Untreated Diffuse Large B-Cell Lymphoma.

Bungo Saito, MD, Eisuke Shiozawa, M.D, Takako Usui, M.D, Hidetoshi Nakashima, M.D, Takashi Maeda, M.D, Norimichi Hattori, M.D, Daisuke Adachi, M.D, Toshiko Yamochi-Onizuka, M.D, Masafumi Takimoto, M.D, Tsuyoshi Nakamaki, M.D, Hidekazu Ota, M.D, Shigeru Tomoyasu, M.D

Blood (2006) 108 (11): 2032.

https://doi.org/10.1182/blood.V108.11.2032.2032

Published: 2006

NARROW

Therapeutic switch from plasma to recombinant ADAMTS13 for patients with congenital TTP from Japanese real-world data

Impact of Red Cell Distribution Width on Dysplasia and Clinical Outcome in 66 Patients with Myelodysplastic Syndrome without Increased Blasts

Increased C-Reactive Protein Level Is Associated with Poor Prognosis in Patients with Follicular Lymphoma Treated with Rituximab-Containing Regimens

Differential Expression of IL-17 Correlates with Clinical and Pathological Features of ITP

High-Dose Ara-C, Carboplatin, Etoposide, and Steroids (ACES) Is Effective in Relapse and Refractory Non-Hodgkin Lymphoma

Soluble Interleukin-2 Receptor and C-Reactive Protein Levels Are Associated with the Efficacy of Bendamustine As a Salvage Treatment for Indolent Lymphoma

Rituximab-Induced CD20-Mediated Signals and Suppression of PI3K-AKT Pathway Cooperates to Inhibit B-Cell Lymphoma Growth By Down-Regulation of Myc.

ASXL2 Is Recurrently Mutated in t(8;21) AML and Regulates Hematopoietic Development

Immunohistochemical Expression of CD123 Is Associated with an Inferior Clinical Outcome in Acute Myeloid Leukemia

Detection of Microbial Substitution in the Oral Cavity of Patients Undergoing Hematopoietic Stem Cell Transplantation with Vitek MS TM , a MALDI-TOF Mass Spectrometry System

Scoring System Using Age, C-Reactive Protein, Hemoglobin, and Albumin (ACHA) For Predicting Outcomes Of Diffuse Large B-Cell Lymphoma In The Rituximab-Era

Comprehensive Profiling of Somatic Mutations Which Define Primary Disease and Relapse in Various Acute Leukemia Subtypes

Constitutive Cyclin A1 Expression Impairs Retinoic Acid-Induced Growth Arrest and Differentiation of Myeloid Leukemia Cells

Constitutive Cyclin A1 Expression Induces Abrogation of Cell Cycle Check Points Associated with Ara-C Resistance in Myeloid Leukemia Cells.

Constitutive Cyclin A1 Expression Inhibits Cytosine Arabinoside-Induced Apoptosis in Myeloid Leukemia Cells.

Characterization of Double BCR-ABL–positive Cell Lines Established from a Patient with Blasic Crisis of Chronic Myeloid Leukemia Who Showed Clinical Resistant to Imatinib

Treatment Effect of Rituximab Plus Chemotherapy Is Obtained by Improving Survival from Non-Germinal Center-Type Untreated Diffuse Large B-Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only